Related Experiment Videos

Refining breast cancer risk assessment with molecular markers: the next step?

M J Ellis, D F Hayes

Journal of the National Cancer Institute

|December 22, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Development of a Telehealth Intervention to Improve Access to Live Donor Kidney Transplantation.

Transplantation proceedings·2019

Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).

Annals of oncology : official journal of the European Society for Medical Oncology·2018

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome.

Breast cancer research and treatment·2017

See all related articles